Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
15.26
-0.22 (-1.42%)
Oct 12, 2026, 1:32 PM EDT - Market open
Ultragenyx Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $19 | Hold | Maintains | $19 | +24.51% | Oct 9, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $20 | Hold | Maintains | $20 | +31.06% | Oct 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +63.83% | Oct 8, 2026 |
| Evercore ISI | Evercore ISI | Hold Maintains $16 → $18 | Hold | Maintains | $16 → $18 | +17.96% | Sep 21, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $18 → $20 | Hold | Reiterates | $18 → $20 | +31.06% | Sep 21, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $33 | Buy | Maintains | $33 | +116.25% | Sep 18, 2026 |
| Wedbush | Wedbush | Hold Maintains $23 | Hold | Maintains | $23 | +50.72% | Sep 18, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $37 → $39 | Buy | Reiterates | $37 → $39 | +155.57% | Sep 18, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.